Loading
This role provides regional leadership, vision, and strategic direction for medical affairs of the Solid tumours asset(s) and disease area(s) with a focus on Women’s Cancer, lung and GU, in collaboration with global and LOCs medical and regional cross-functional teams. This role is critical in proactively maximizing the positive impact within the Medical Value Proposition (MVP) and Medical Impact Framework (MIF) to ultimately improving patient care and health outcomes.
As the RMAL, the incumbent will be accountable for ensuring that the medical teams in the countries for the related asset(s) and disease area(s) have the right capabilities for execution and performance of their medical operational plans.
The RMAL will play a key role in aligning with the Global strategy for the relevant asset(s) and disease area(s) with a focus on lung and GU and will bridge appropriately between Global, Region and LOC Medical as well as cross functional stakeholders within Medical and with Commercial and Market access/CGA counterparts with a focus on priority markets in the region.
Be the single point accountable for the of the Solid tumours asset(s) and disease area(s) with a focus on Women’s Cancer, lung and GU asset(s) and disease area(s) related Medical Affairs activities across the region.
Ensure the medical voice of the customer (HCP, Payers/Decision makers, Patient) and market is deeply understood, synthetized into medical actionable insights for global strategy and enable appropriate use of our medicines
Lead the development and execution of globally and cross-functionally aligned medical plans for the relevant asset(s) and disease area(s) within the region. This role will not duplicate the roles and responsibilities of the global or local medical affairs teams for the asset(s) and disease area(s).
Lead the scientific and external engagement strategy for the asset(s) and disease area(s) within the region. Build strong external networks among the regional scientific societies and institutions.
Co-create with regional evidence generation lead for the asset(s) and disease area(s), a consolidated regional perspective into long-term regional and global clinical and value evidence strategies.
Work closely with LOCs and regional Evidence Generation team to ensure understanding of LOC needs and accelerate approval timelines by the global organisation.
Ensure the medical input into LOCs’ Launch Excellence plan’ for relevant asset(s), this includes launch improvement workshops, LOC deep dives, and brand clinics.
Lead on capability development for relevant asset(s) and disease area(s) among LOC medical affairs teams, includes but is not limited to IMEPs.
Enhance quantitative and qualitative scientific share of voice at regional non promotional events: scientific congresses, healthcare conferences, regional summits and scientific workshops.
Foster the medical value proposition through seamless cross-functional partnership (Evidence, generation, Commercial, Market Access/CGA), to ensure patients access and outcome.
Basic Qualifications
Master’s Degre, Life Sciences preferred
Solid grounding in clinical, medical and pharmaceutical science with the ability to rapidly assimilate, specific and detailed knowledge in the relevant therapy area and be the single point of accountability for the Solid tumours asset(s) and disease area(s) with a focus on Women’s Cancer, lung and GU in the region
Extensive experience in working in pharmaceutical industry in Oncology
Experience working in medical affairs and in a matrix environment and managing senior stakeholders effectively
Strong business acumen with excellent strategic thinking, communication, stakeholders influencing and leadership skills
Demonstrated ability to build collaborative relationships
Experience in evaluating and effectively communicating evidence-based medicine
Track record of building strong internal and external networks
Demonstrated ability to manage complexity and international cultural diversity
Strong interpersonal, verbal, and written communication skills in English
Evidence of alignment to GSK Values, Code and standards and acts as role model to teams, peers and matrix stakeholders.
Preferred Qualifications
MD/ Medical Degree / Pharmacy Degree
Good scientific acumen and data analysis and interpretation
Robust knowledge of regulatory / market access and reimbursement requirements, with understanding of drug development
Understanding of internal codes of practice and policies and external regulations
Demonstrated ability to assess evidence generation needs; review Phase IV protocols and ISSs for scientific merit
Skills
Why GSK?
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.
We are committed to creating an inclusive workplace and providing equal opportunities for all applicants. We embrace an agile working culture across our roles, so if flexibility is important to you please discuss opportunities with our hiring team. If you need any adjustments to the recruitment process to help you demonstrate your strengths and capabilities, contact APACRecruitment.Adjustments@gsk.com. Please note this email is for adjustment requests only; for other enquiries please use our standard contact channels.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.